Studies have shown that active fund managers routinely underperform the S&P500 index*​

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)

KMTS Stock Predictions and Ratings

WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-8.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-28.90%

KMTS Stock Analysis

KMTS PE Ratio:

KMTS PEG Ratio: Not Available

KMTS Forward EPS Growth (12 month): 0.00%

KMTS PS Ratio: 13.1

KMTS PSG Ratio: -12443.7

KMTS Forward Revenue Growth (12 month): 0.00%

KMTS Articles

No data was found